Showing results (51-60 of 107) with videos related to
Sort By:
Pageof 11
BMC Medicine|January 9, 2010
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group studyDimitrios Bafaloukos, Helena Linardou, Gerasimos Aravantinos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patients with resected high-risk melanomaDimitrios Pectasides, Urania Dafni, Dimitrios Bafaloukos, et al.Plos One|March 19, 2014
Differential expression of the insulin-like growth factor receptor among early breast cancer subtypesGiannis Mountzios, Dimitra Aivazi, Ioannis Kostopoulos, et al.Breast Cancer Research and Treatment|August 1, 2008
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trialGeorge Pentheroudakis, Konstantine T Kalogeras, Ralph M Wirtz, et al.Clinical Breast Cancer|January 22, 2016
Safety and Tolerability of Anthracycline-Containing Adjuvant Chemotherapy in Elderly High-Risk Breast Cancer PatientsVasilios Karavasilis, Christos Papadimitriou, Helen Gogas, et al.Anti-Cancer Drugs|May 29, 2004
Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG)Jim Janinis, George P Stathopoulos, Pavlos Nikolaidis, et al.BMC Cancer|May 10, 2015
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancerDimitrios Pectasides, Vasilios Karavasilis, George Papaxoinis, et al.Breast Cancer Research and Treatment|July 11, 2006
Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survivalLida Kostadima, George Pentheroudakis, George Fountzilas, et al.Breast Cancer Research and Treatment|June 28, 2005
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology GroupGeorge Fountzilas, Dimitrios Pectasides, Anna Kalogera-Fountzila, et al.Oncology Reports|October 26, 2011
Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) studyDimitrios Pectasides, George Papaxoinis, Vassiliki Kotoula, et al.Pageof 11